1,188 filings
Page 4 of 60
8-K
yfofasm3qn
2 Mar 20
VIVUS Completes Enrollment in Phase 4 Safety and Efficacy Study of
7:43am
4
sej1r04pw7kj7b
24 Feb 20
VIVUS / HERM ROSENMAN ownership change
6:07pm
4
vilq 8bf00
24 Feb 20
VIVUS / Jorge MD Plutzky ownership change
6:06pm
4
j0enj6u8t5w750
24 Feb 20
VIVUS / David Y Norton ownership change
6:06pm
4
oi4qfdc43kbpbwm
24 Feb 20
VIVUS / THOMAS BRAXTON KING ownership change
6:06pm
4
vk0pxsrfuxc3
24 Feb 20
VIVUS / EDWARD A KANGAS ownership change
6:05pm
4
vfhzx6ua83fo3uj
24 Feb 20
VIVUS / Karen E. Ferrell ownership change
6:05pm
8-K
cnc2 8bfd7894pswv
21 Feb 20
Departure of Directors or Certain Officers
4:05pm
8-K
r905qj2la zn9
19 Feb 20
VIVUS Announces Commercial Launch of Qsymia®in the Republic of Korea Establishing New Royalty Revenue Stream
7:35am
SC 13G/A
2y5ubdmoxrtjhj89c7qd
13 Feb 20
Vivus Inc
12:00am
8-K
tu7ea5nq6k 7ky5
5 Feb 20
VIVUS Receives U.S. Food and Drug Administration Approval for Improved Formulation of PANCREAZE® with a 36-Month Shelf Life
7:35am
SC 13G
s0irk774djl229ymab2w
4 Feb 20
Beneficial ownership report
4:03pm
4
46ghv2sq9j q4u
31 Jan 20
VIVUS / John P. Amos ownership change
5:25pm
4
ru1ftfs tg0kjjdg5kfq
31 Jan 20
VIVUS / Mark K Oki ownership change
5:25pm
4
te4o69igmzkw
31 Jan 20
VIVUS / John L Slebir ownership change
5:24pm
4
gf4xjd
31 Jan 20
VIVUS / Santosh T Varghese ownership change
5:23pm
8-K
mmsxajs34
31 Jan 20
Departure of Directors or Certain Officers
4:35pm
8-K
u5ekxk wj0gww
7 Jan 20
Other Events
7:35am
8-A12B
4ngg13j0yehk8b
31 Dec 19
Registration of securities on exchange
7:50am